PENGOBATAN KOMBINASI DARI PENGHAMBAT ENZIM PENGUBAH ANGIOTENSI DAN ANTAGONIS ALDOSTERON UNTUK MENURUNKAN MORBIDITAS DAN MORTALITAS DARI PENYAKIT KARDIOVASKULER

摘要

Combinations of an ACE inhibitor, an aldosterone antagonist, and a loop diuretic are described for use in treatment of circulatory disorders. Of particular interest are therapies using captopril, enalapril or lisinopril co-administered with spironolactone. This co-therapy would be particularly useful to reduce the death rate or the number of non-fatal hospitalizations or prevent the progression of congestive heart failure in patients with cardiovascular disease.